nl escp 170 vf_bis
TRANSCRIPT
The tri-monthly newsletter of the European Society
of Clinical Pharmacy News
ESCP News
ESCP News
ESCP News
ESCP News �� �� February 2016
February 2016
February 2016
February 2016 �� �� Number 170
Number 170
Number 170
Number 170 �� �� ISSN 135
ISSN 135
ISSN 135
ISSN 13533 33-- -- 0321
0321
0321
0321
A Few Words
1
ContentsContentsContentsContents : A Few words 1 ESCP life 2 Articles & Reports 4 ESCP Conferences 7 Announcements 8
Only a few weeks ago the most important ESCP event of the year – the autumn sym-posium – took place in Lisbon. The main topic was medicines information and how this contributes to better decision making. To sharing and exchange of information is the unwritten main purpose of any event of this kind, and this transfer of information reaches far beyond the scientific pro-gramme where speakers and the audi-ence interact. The autumn symposium is one of the very rare occasions where the members of our society gather, where they meet old friends and find new ones, an occasion where we come together from all over Europe and from other distant parts of the world like a big family does to celebrate Christmas, and an occasion where the leadership of ESCP can meet face to face and not only virtually as during the rest of the year in Skype conferences, telephone meetings or e-mail correspondence.
These real meetings are – in my experi-ence – the most important drivers to bring an organisation forward. For this reason a great number of formal meetings of com-mittees and between committees, along with informal meetings take place before, during and after the symposium. For exam-ple the General Committee met for a whole day before the conference, all the commit-tees, the research, the education, the com-munication committee, and the SIG council have their meetings, scientific and organi-sation committees for next conferences or workshops also meet in this period. To report on all the discussions and decisions would fill pages and it is therefore not the right place to do it here. However, I would like to point out some topics from these many meetings which from my perception as president are of signifocant importance for ESCP.
1/ Perhaps you remember the survey sent 1/ Perhaps you remember the survey sent 1/ Perhaps you remember the survey sent 1/ Perhaps you remember the survey sent out by ESCP about “clinical pharmacy/out by ESCP about “clinical pharmacy/out by ESCP about “clinical pharmacy/out by ESCP about “clinical pharmacy/pharmaceutical care” during this year. pharmaceutical care” during this year. pharmaceutical care” during this year. pharmaceutical care” during this year. We have got the results which have been dis-cussed also in the GC meeting. The survey
gives a very interesting and valuable in-sight in the practice of clinical pharmacy and pharmaceutical care across Europe and reveals important aspects for the definition of either of the terms. Our two GC members, Tobias Dreischulte and Fer-nando Fernandez-Llimos, are close to finalising a publication on this survey. The GC will, based on these findings, continue in the process of elaborating a new defini-tion of clinical pharmacy. In this process a broad participation of our members will be important. A clear, precise and well ac-cepted definition of clinical pharmacy as a scientific discipline and a pharmaceutical practice is indispensable for many pur-poses.
2/ One of these purposes is to give the 2/ One of these purposes is to give the 2/ One of these purposes is to give the 2/ One of these purposes is to give the events of ESCP a clear profile. events of ESCP a clear profile. events of ESCP a clear profile. events of ESCP a clear profile. ESCP should be recognized as THE leading European society for clinical pharmacy and clinical pharmacists. To achieve, all topics of and contributions to ESCP conferences ought to be within the scope of clinical pharmacy. One way to maintain the focus on clinical pharmacy is the abstract review process. This topic has caused some controversial discussion in the past.
Both reviewers and submitters, have not always been fully satisfied with the proc-ess. In order to improve the review proc-ess, and establish reliable and transparent criteria, thorough discussions have taken place during the past few months, but especially during the autumn symposium in different committees. For me personally the most important point in all the discussions was that in the end we all have agreed that the review process should be encouraging for young researchers to present their work in our conferences. This means that not only perfectly designed studies should get the chance to be accepted as an oral commu-nication but also contributions showing innovative ideas or having the potential to initiate a scientific debate to advance clini-cal pharmacy.
3/ What I have reported so far here goes in 3/ What I have reported so far here goes in 3/ What I have reported so far here goes in 3/ What I have reported so far here goes in parallel with the strategic planning of ESCP parallel with the strategic planning of ESCP parallel with the strategic planning of ESCP parallel with the strategic planning of ESCP which we presented in the General Assem-which we presented in the General Assem-which we presented in the General Assem-which we presented in the General Assem-bly 2014. bly 2014. bly 2014. bly 2014. Since this presentation all the committees have taken the opportunity to discuss the strategic planning and were working on the question of what their spe-cific contribution should be. It was for me as president a great pleasure to see during the Lisbon conference how the spirit of the new strategy has reached the committees, how ideas have been generated and how enthusiastically some people have got involved in the process. A good beginning is made, but for the next two to five years it will be a challenge to keep on track. To support us all to do so, the GC appointed our past president, Siska Desplenter, as a change manager. She is committed to helping us in the process, to reach mile-stones and to keep an eye on timelines.
As I mentioned in the beginning of this article, conferences are a perfect occasion to share information. I wish for all of us that we can use this information, whether it is scientific, organisational or personal infor-mation, for better decisions and better practice. Always remember Steve Hudson who used to say: “Information is not knowl-edge, knowledge is not understanding, understanding is not wisdom, wisdom is not empathy, empathy is not care.”
Markus LampertMarkus LampertMarkus LampertMarkus Lampert [email protected]
E u r o p e a n S o c i e t y o f C l i n i c a l P h a r m a c y The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by The overall aim of the Society is to develop and promote the rational and appropriate use of medicines by the individual and by society.society.society.society.
The strategic plan of ESCPThe strategic plan of ESCPThe strategic plan of ESCPThe strategic plan of ESCP
ESCP News
ESCP News
ESCP News
ESCP News �� �� February 2016
February 2016
February 2016
February 2016 �� �� Number 170
Number 170
Number 170
Number 170 �� �� ISSN 135
ISSN 135
ISSN 135
ISSN 13533 33-- -- 0321
0321
0321
0321
ESCP Life
2
Bart van den BemtBart van den BemtBart van den BemtBart van den Bemt, born on the 3th of July 1972 in Breda, The Netherlands.
Education/work activityEducation/work activityEducation/work activityEducation/work activity After earning my master degree in phar-macy at the University of Utrecht (The Neth-erlands), I started as a community phar-macy in a small rural village in the western part of the Netherlands (“Ter Aar”). There, in 1996 I received my qualification as com-munity pharmacist. After three years, I decided to broaden my experience and started as pharmaceutical care-developer for a franchise formula for community phar-macies. However, I missed direct patient care and therefore I switched job in 2003 to become an outpatient pharmacist and clinical scientist at the departments of Pharmacy in the Sint Maartenskliniek and (since 2013) the Radboud University Medi-cal Center in Nijmegen, The Netherlands. In my current challenging job, I can combine patient care, scientific research and policy making. In 2009 I received my Ph.D. de-gree in Medical Sciences with his thesis “Optimizing Pharmacotherapy in Patients with Rheumatoid Arthritis: an individualized
approach ”. Last year, I earned my degree as clinical pharmacologist.
Besides my work as pharmacist, I am also vice-president of the Dutch Association of Hospital Pharmacist and the president of the “Center of Patient and Medication”. This latter foundation aims to empower patients to be more involved in (decisions about) their medications and educates healthcare providers to increase patient involvement.
Personal driversPersonal driversPersonal driversPersonal drivers As (1) 3-5% of all hospital admissions are related to (often preventable) drug related problems, (2) half of the patients do not adhere to their pharmacotherapy and (3) the cost-effectiveness of pharmacotherapy can still be optimised, my personal driver is to improve the effectiveness, safety, cost-effectiveness and patient-satisfaction with pharmacotherapy.
Although improving pharmacotherapy is of course a multidisciplinary responsibility, I think that clinical pharmacists (with their skills as expert in pharmacotherapy and pharmaceutical care) have excellent com-petencies to play (together with the patient) a key role in pharmaceutical care. Keeping this in mind, I therefore collabo-rate with other healthcare professionals in order to develop pharmaceutical care pro-grams and educational programs. In order
to identify and quantify the outcomes of pharmaceutical care my research interests are currently focused on Individualised Pharmacotherapy including medication adherence, medication review, transitional care, therapeutic drug monitoring of biologi-cals, inflammatory (rheumatic) pain and medication wastage.
ESCP activitiesESCP activitiesESCP activitiesESCP activities I love to collaborate with other ESCP-members in order to improve pharmaceuti-cal patient care. I think clinical pharmacists have an important role in the optimization of outcomes of drug therapy, making drug therapy more (cost-)effective, safer and more patient-oriented.
This is one of the reasons I constituted a new ESCP-special interest group on medi-cation adherence and also organise to-gether with other ESCP-members a spring workshop on medication adherence in June in Basel. For me it is an honour to be elected to the ESCP general committee. As board member I hope to further optimise current ESCP activities and also to intro-duce new (educational) products. These new products will foster the position of the ESCP and the clinical pharmacists with ultimately one goal: better patient care!
Bart van den BemtBart van den BemtBart van den BemtBart van den Bemt [email protected]
Who’s who? Who’s who? Who’s who? Who’s who? Bart van den BemtBart van den BemtBart van den BemtBart van den Bemt New GC member
Stephane Steurbaut, Stephane Steurbaut, Stephane Steurbaut, Stephane Steurbaut, born on the 16th of February 1973 in Watermaal-Bosvoorde, Belgium.
Education/work activityEducation/work activityEducation/work activityEducation/work activity After obtaining my master degree of phar-macy at the Free University of Brussels (VUB, Belgium) in 1996, I started a PhD in Pharmaceutical Sciences in the domain of Virology and completed this in 2007. Dur-ing this time, I followed the Master-after-Master programme in Industrial Pharmacy and received this degree in 1999. I also kept working in community pharmacies since my graduation. In 2007 and despite this rather atypical background, I was of-fered a position at the department of Clini-cal Pharmacology and Pharmacotherapy in the University Hospital of Brussels (UZ Brussel) where I coordinate the clinical pharmacy programme among other things. As the secretary of the Drugs and Thera-peutics Committee, I also have the privilege to come in contact with many aspects of medicines ranging from pharmacovigilance
to pharmaco-economics and from pharma-cology to policy making. In 2010, I was appointed as assistant professor at the VUB teaching pharmaceutical care to final year pharmacy students and aspects of clinical pharmacy to hospital pharmacy students. Altogether, the combination of these duties is quite demanding but in-credibly interesting and provides a lot of satisfaction.
Professional personal drivers/interestsProfessional personal drivers/interestsProfessional personal drivers/interestsProfessional personal drivers/interests The combination of both working in the community pharmacy setting as well as in a hospital made me realise that a lot of drug related problems arise from commu-nication gaps between the different health care settings. These gaps are potentially life-threatening and consequently have to be avoided as much as possible. Develop-ing transmural/seamless care pro-grammes is a way to mitigate these prob-lems. As a consultant to the Belgian Fed-eral Health Department I try to raise aware-ness for and stimulate the creation of such programmes thereby working together with fellow pharmacists as well as other health care professionals, e.g., physicians, nurses and members of hospital boards. Apart from collaborative care and shared decision making, I am particularly inter-ested in clinical decision support system (CDSS) incorporating medications and patient characteristics (e.g. drug-drug, drug-
disease and drug-laboratory CDSS). The vast amount of medical information makes it (almost) impossible to keep track or to always apply this knowledge correctly at the individual patient level. I believe that performant CDSS can increase patient safety and free up time for e.g. pharmacists to spend more time on patient counselling or the analysis of complex cases. In that respect it could be an good idea to create an ESCP SIG on CDSS. My other research interests currently include antithrombotics, medication adherence, medication review and pharmacovigilance.
ESCP activititiesESCP activititiesESCP activititiesESCP activitities I’m an ESCP member since 2008 and believe that knowledge sharing is funda-mental to improving patient safety. Ex-changing ideas with fellow pharmacists, attending and giving presentations and/or moderating workshops are great ways to achieve this goal and are the core of the society. That’s the reason why in 2015 I decided to apply for the vacant General Committee (GC) position for an ESCP mem-ber from Belgium and was honoured to be elected. Within the GC, the Education Com-mittee and the Vision and Mission portfolio I will do my utmost to serve and reinforce all aspects of clinical pharmacy.
Stephane SteurbautStephane SteurbautStephane SteurbautStephane Steurbaut
Who’s who? Who’s who? Who’s who? Who’s who? Stephane SteurbautStephane SteurbautStephane SteurbautStephane Steurbaut New GC member
ESCP News
ESCP News
ESCP News
ESCP News �� �� February 2016
February 2016
February 2016
February 2016 �� �� Number 170
Number 170
Number 170
Number 170 �� �� ISSN 135
ISSN 135
ISSN 135
ISSN 13533 33-- -- 0321
0321
0321
0321
ESCP Life
3
In memory of Chiel Hekster (1947In memory of Chiel Hekster (1947In memory of Chiel Hekster (1947In memory of Chiel Hekster (1947----2015)2015)2015)2015)
Prof. dr. Chiel HeksterProf. dr. Chiel HeksterProf. dr. Chiel HeksterProf. dr. Chiel Hekster, past presi-dent and fellow of the European Society of Clinical Pharmacy (ESCP), deceased on November 17th 2015. Chiel Hekster was, besides many other additional functions, Professor Emeritus of the Department of Clini-cal Pharmacy at the Radboud Uni-versity Medical Centre. Our profes-sion owes him a big debt of grati-tude. Although we will miss Chiel, his influence on clinical pharmacy will live on.
Chiel was born in 1947 in Bandung, Indonesia, and later moved with his parents to the Netherlands. After earning his degree as pharmacist in 1972, Chiel fulfilled his military service at the Military Blood Transfu-sion Service in Amsterdam. His in-volvement with blood products was continued after his military service, when he assigned the job as head
of the Pharmaceutical Laboratory of the production department of the Central Laboratory of the Nether-lands Red Cross Blood Transfusion Service (CLB).
In 1976 Chiel moved to Nijmegen to carry out both his doctoral study and his training as hospital pharma-cist. The title of his thesis was: "Selection criteria for antimicrobial drug utilisation" which he defended on June 3, 1983. During the 34 years in Nijmegen, Chiel was the personification of a patient-oriented, innovative clinical pharmacy. He introduced, for example, ward based pharmacy services performed by pharmacy technicians. Besides his clinical activities Chiel was also a trainer of hospital phar-macist and clinical pharmacologists, and a member of the Medical Re-search and Ethics Committees, the antibiotic committee and depart-ment head (1994-2000). Mean-while he registered as clinical phar-macologist (1993) and was ap-pointed in 1998 as Professor of Clinical Pharmacy at the Radboud University Nijmegen. He continued this chair until 2010 when he re-tired. Chiel’s research I focused on many areas such as antibiotics,
epilepsy and drug safety. He suc-cessfully supervised more than 20 PhD students.
Besides his work at the Radboud University Medical Centre, Chiel had many other positions. He played an active role in the Dutch Association of Hospital Pharmacists, especially with respect to education, research and patient oriented pharmacy. Furthermore, Chiel was member of the Dutch Medicines Evaluation Board (1992 - 2015), member and chairman of the advisory board of the Netherlands Pharmacovigilance Centre Lareb (1997 - 2010), and editor of the Dutch Pharmaceutical Journal & PW Scientific Edition (1986-1991).
Among others, Chiel was interna-tionally involved as president of the European Society for Clinical Phar-macy (2000-2002) and member of the WHO Drug Utilization Research Group (1978-1995).
Chiel was a passionate and enthusi-astic figurehead for clinical phar-macy. We will miss his original and unconventional thinking, reflections, cordiality and collegiality and are grateful to him for everything he did for us and the patients.
For the next two years, Siska Desplenter will further support the ESCP General Committee as ‘process manager’. The aim of this function is to guarantee the implementation of the ESCP strategic plan for the future as it was presented during the General Assembly 2014 in Copenhagen. Siska will support the GC in this task by defining milestones of the
strategic items, defining and follow-up on deadlines. New composition of the GCNew composition of the GCNew composition of the GCNew composition of the GC Markus Lampert (CH), President Tobias Dreischulte (UK), secretary Olivier Bourdon (F), Treasurer Daniela Scala (I), member Anne Gerd Granås (N), member
Fernando Fernandez-Llimos (PT), mem-ber New GC members New GC members New GC members New GC members (see Who’s who p.2) - Bart van den Bemt (NL) [email protected] - Stephane Steurbaut (B) [email protected]
News from the GCNews from the GCNews from the GCNews from the GC
Like every year the ESCP presents at the end of the Symposium an award for the best poster and the best oral communi-cation. Everyone is invited to submit abstracts for consideration.
- The best poster presentation winner (HP-PC131) is Pauline-Sanaï Zeller ([email protected]), from Reims, France, for “Medication management optimisation for surgical patients”.
- The best oral communication winner (CP-PC010) is Sanne Verdoorn ([email protected]), from Lei-den & Utrecht, Netherlands, for “A com-parison of drug-related problems before and after the introduction of a clinical decision support system during medica-tion review”. Congratulations to the winners!
Sanne Verdoorn (from the Netherlands), with Mar-garida (Chair SC) and Markus (President ESCP).
44444444thththth ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy Lisbon, Portugal, 28Lisbon, Portugal, 28Lisbon, Portugal, 28Lisbon, Portugal, 28----30 October 201530 October 201530 October 201530 October 2015
ESCP Poster Award and ESCP Poster Award and ESCP Poster Award and ESCP Poster Award and Oral Communication Award 2015Oral Communication Award 2015Oral Communication Award 2015Oral Communication Award 2015
ESCP News
ESCP News
ESCP News
ESCP News �� �� February 2016
February 2016
February 2016
February 2016 �� �� Number 170
Number 170
Number 170
Number 170 �� �� ISSN 135
ISSN 135
ISSN 135
ISSN 13533 33-- -- 0321
0321
0321
0321
ESCP Life
4
On behalf of the European Society of Clini-cal Pharmacy we thank your participation in the 44th ESCP Symposium in Lisbon, Portu-gal.
The main theme of the symposium was “Medicines Information – making better decisions” with the focus on Medicines Information”.
Regardless of which definition of clinical pharmacy is used, clinical decision making is fundamental to improve the current drug therapy of patients and also to drug therapy outcomes. However due to the rapid growth of the therapeutic portfolio, clinical pharma-cist may not have enough knowledge to make some clinical decisions.
Medicines information is usually defined as a knowledge that a healthcare professional lacks and has to access during the clinical decision-making process. It is essential to assess the quality of the information by considering its accessibility, reliability, com-pleteness and applicability. New technolo-gies may improve access to medicines information, but are associated with new requirements related to their special char-acteristics. The scientific components began with a Master Class of Excellence in Pharmacy as a pre-scientific day about “Practice Re-search: easing the progress from research idea to research proposal”. Developing a research idea into a research proposal can appear a daunting task, whether it relates to project to be conducted as part of every-day clinical practice or an application to a grant awarding body for large sums of money. The participants improved their knowledge, understanding and skills relat-ing to research proposal development.
In the first day, Wednesday 28, the topic was “Official Medicines Information “Official Medicines Information “Official Medicines Information “Official Medicines Information Sources”Sources”Sources”Sources” in the morning, we had as invited speakers Guido Rasi, Executive Director European Medicines Agency (EMA) and Bruno Sepodes, chair of the Committee for Orphan Medicinal Products, also from EMA; in the afternoon the topic was “The futures “The futures “The futures “The futures of medicines information”of medicines information”of medicines information”of medicines information” with Hanna Seidling, Melinda Cuthbert and David Woods, presenting on “Clinical decision support systems – what help do they offer, what harm can they bring?”, also “Medicines information education – equip-
ping the next generation of pharmacists” and “Creation of a national dataset of drug alert groups for clinical decision support – a focus on drug allergy”, respectively. In the second day, Thursday 29, the topic was “Drug Industry as medicines informa-“Drug Industry as medicines informa-“Drug Industry as medicines informa-“Drug Industry as medicines informa-tion providers” tion providers” tion providers” tion providers” in the morning presenters were Helder Mota-Filipe with “Information and risk management”, Ana Nogueira “From science to value, from medicines to people” and Tim Reed “Fifty shades of grey: where does information stop and advertis-ing start?”; in the afternoon about “Drug “Drug “Drug “Drug Information Centres” Information Centres” Information Centres” Information Centres” there were topics and lectures “Combining explicit criteria and implicit human judgment in multidiscipli-nary medication chart review in older adults: a complex exercise in clinical deci-sion making with physicians, pharmacist and nurses” by Robert Vander Stichele, “Translating official medicines information into practical tools for pharmacists” by Sophie Sarre and “Medicines information services, traditional and modern: evidence/practise – based support for the pharma-cist and the patient” by Lelie-van der Zande. Last day, Friday 30 the presentations were about “Evidence“Evidence“Evidence“Evidence----Based decision making” Based decision making” Based decision making” Based decision making” with “Interpreting the evidence; challenges when making decision about funding drugs” by Amanda Adler, “Where health economics meet evidence-based decision making” by Barbara Claus and “Pharmacists in primary care: evidence-based practice is more than the outcomes” by Karen Farris. All day was scheduled as a sequence of 20 workshops organized by the different spe-cial interest groups of ESCP, Research and Education Committee, General Committee of ESCP and also some chosen by the Sci-entific Committee of the 2015 Lisbon ESCP Symposium. The topics were: WS 01. Successful scientific writing: getting conference abstracts accepted; WS 02. Successful scientific writing - origi-nal research papers; WS 03. Planning and running a workshop; WS 04. Evaluating clinical pharmacy ser-vices – a research clinical workshop; WS 05. Identifying and improving adher-ence: a shared effort for patients and clini-cal pharmacists; WS 06. Probiotic supplements uses, safety and clinical effect; WS 07. An app for ethics - to recognize and solve ethical problems in pharmacy prac-tice and research; WS 08. The active role of medicines infor-mation pharmacists in Evidence Based Practice and medicines optimisation; WS 09. Implementation and quality control
with the Model for improvement ; WS 10. Making better decisions based on medicines information – how to find and critically; appraise relevant literature; WS 11 Patient safety through advanced clinical decision support systems in your pharmacy; WS 12. Understanding and evaluating systematic reviews and meta-analyses; WS 13. Making a difference to medication safety – understanding medication errors to develop local improvement strategies; WS 14. Information Pharmacist – do you fulfil your role?; WS 15. Herb-drug interactions as one of the possible causes of chemotherapy fail-ure; WS 16. Cancer therapy in pregnant women – struggle for mother and child; WS 17. Best practices to improve self-management of oral oncolytics; WS 18. How providing an accurate answer to a clinical question within 10 minutes; WS 19. How to select and implement clini-cal decision support systems; WS 20. From adherence to concordance – role of the clinical pharmacist. There was a variety of clinical pharmacy research and practical work represented by 20 oral communications, and around 200 posters of which them 20 were also pre-sented in a oral session and to complete the previous plan have on Thursday (12-12.30) we had the Steve Hudson Lecture. With this programme we contributed to opening the minds and expectations of the clinical pharmacists to access up to date medicines information, filtering the knowl-edge to generate the evidence that may be required to make the best possible orienta-tion to the physicians, nurses and patient. We discussed all these topics in Lisbon and we have learned about the correct deci-sions, that patients need to have good outcomes with safe drugs uses.
With the social program we felt the friend-ship and enthusiasm of the participant and we must say thanks for all. You have learned about Lisbon and about the ESCP. Thanks for coming!
Margarida CaramonaMargarida CaramonaMargarida CaramonaMargarida Caramona President of Scientific Committee
Fernando FernandezFernando FernandezFernando FernandezFernando Fernandez----LlimosLlimosLlimosLlimos President of the Lisbon Symposium
44444444thththth ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy
Lisbon, Portugal, 28Lisbon, Portugal, 28Lisbon, Portugal, 28Lisbon, Portugal, 28----30 October 201530 October 201530 October 201530 October 2015
ESCP Lisbon SymposiumESCP Lisbon SymposiumESCP Lisbon SymposiumESCP Lisbon Symposium
ESCP News
ESCP News
ESCP News
ESCP News �� �� February 2016
February 2016
February 2016
February 2016 �� �� Number 170
Number 170
Number 170
Number 170 �� �� ISSN 135
ISSN 135
ISSN 135
ISSN 13533 33-- -- 0321
0321
0321
0321
Articles & Reports
5
The ESCP Masterclass was attended by seven participants from across Europe and wider afield, with varying levels of experi-ence in pharmacy practice research and research protocol development.
The overall aim of the Materclass was to lead participants through the key stages of proposal development, enabling them to turn a research idea into a research pro-posal. Emphasis was placed on developing transferable skills appropriate to any re-search proposal, irrespective of the amount of funding or even no funding being available.
Sessions were a blend of plenaries, small group working, feedback and discussion. These covered key issues of: The generic sections of any research pro-The generic sections of any research pro-The generic sections of any research pro-The generic sections of any research pro-posalposalposalposal - The criteria used by reviewers in assess-ing a research proposal for example
• Clarity of research aim and questions
• Appropriate methodology and method to answer the questions
• Likely impact and pathway to impact
• Value for money
• Team expertise - Characteristics of the ideal research team for example
• Expertise
• Psychological profiles - Benefits of patient and public involve-ment in all stages of research from formu-lating research aims and questions to dissemination of research findings - Resources required to conduct research and how to justify these - The meaning of research impact and pathways to impact
Participants were encouraged to discuss their own research proposals and plans,
and were encouraged to apply for the ESCP research grant which was an-nounced at the conference. All benefited greatly from the sharing of experiences and networking opportunities provided throughout the Masterclass.
Moderators: Professor Derek Stewart, Professor Derek Stewart, Professor Derek Stewart, Professor Derek Stewart,
Dr John McAnawDr John McAnawDr John McAnawDr John McAnaw
44444444thththth ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy Lisbon, Portugal, 27Lisbon, Portugal, 27Lisbon, Portugal, 27Lisbon, Portugal, 27thththth October 2015 October 2015 October 2015 October 2015
Masterclass ReportMasterclass ReportMasterclass ReportMasterclass Report Excellence in Pharmacy Practice Research: Excellence in Pharmacy Practice Research: Excellence in Pharmacy Practice Research: Excellence in Pharmacy Practice Research:
Easing the Progress from Research Idea to Research ProposalEasing the Progress from Research Idea to Research ProposalEasing the Progress from Research Idea to Research ProposalEasing the Progress from Research Idea to Research Proposal
ESCP would like to assist in the education of clinical pharmacists in developing countries. A way of doing this is to make the ESCP symposia more accessible for pharmacists from these countries. ESCP therefore offers financial support, consisting of free regis-tration to the 11th ESCP European Symposium on Clinical Pharmacy. The pharmacist who requests financial assistance should live and work in a developing country. Here are the colleagues from Thailand and Turkey who get a benefit from granting of financial support.
In granting financial support, priority is given to the following applicants : - ESCP Members, taking into account the duration of their membership; - Applicants whose abstracts have been
accepted for presentation as oral communi-cation or in the poster discussion forum during the symposium; - Applicants with the most experience in clinical pharmacy, which will be determined
by the quality of abstract(s) submitted and the applicants’ Curriculum Vitae; - Applicants who have not previously re-ceived financial support from ESCP.
Dujrudee Chinwong Dujrudee Chinwong Dujrudee Chinwong Dujrudee Chinwong from Thailand: Abstracts CP-CE002 Training pharmacy students on providing smoking cessation at the University Pharmacy: a lesson learned from Thailand. CP-PC017 Community pharmacists’ activities on providing smoking cessation services: Thailand.
Samira MamedovaSamira MamedovaSamira MamedovaSamira Mamedova from Turkey: Abstract HP-PC093 Implementation of medication reconciliation and medication review services conducted by pharmacist in hospitalized COPD patients.
Betul OkuyanBetul OkuyanBetul OkuyanBetul Okuyan from Turkey: Abstracts CP-PC008 Determination of potential drug-drug interactions by using various software programs at community pharmacy setting. DI026 Assessment of attitude and knowledge in patients utilized disposable insulin pens at community pharmacy setting. HP-PC093 Implementation of medication reconciliation and medication review services conducted by pharmacist in hospitalized COPD patients. HP-PC102 Determination of potential drug-drug interactions by using various drug interaction software programs at hospital phar-macy setting. HP-PC105 Evaluation of potentially inappropriate medication use and drug burden index in elderly patients with cancer.
Ceylan PaksoyCeylan PaksoyCeylan PaksoyCeylan Paksoy from Turkey: Abstract HP-PC105 Evaluation of potentially inappropriate medication use and drug burden index in elderly patients with cancer.
Mesut SancarMesut SancarMesut SancarMesut Sancar from Turkey: Abstracts P-PC008 Determination of potential drug-drug interactions by using various software programs at community pharmacy setting. DI005 Drug - drug interaction in patients using proton pump inhibitors: a patient drug profile study. DI006 Determination of potentially drug-drug interaction in oncology patients. DI026 Assessment of attitude and knowledge in patients utilized disposable insulin pens at community pharmacy setting. HP-PC029 Pharmaceutical Care Impact on Certain Biochemical Levels in Diabetic Cancer Patients. HP-PC093 Implementation of medication reconciliation and medication review services conducted by pharmacist in hospitalized COPD patients. HP-PC102 Determination of potential drug-drug interactions by using various drug interaction software programs at hospital phar-macy setting. HP-PC105 Evaluation of potentially inappropriate medication use and drug burden index in elderly patients with cancer. HP-PC120 Determination of pharmaceutical care needs in patients with colon cancer at an ambulatory setting.
Songül Tezcan Songül Tezcan Songül Tezcan Songül Tezcan from Turkey: Abstracts HP-PC120 Determination of pharmaceutical care needs in patients with colon cancer at an ambulatory setting. PT012 Observation of dominant occurrence of radiotherapy related acute side effects and management.
Tab. Financial support winners for the Lisbon Symposium
44444444thththth ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy Lisbon, Portugal, 28Lisbon, Portugal, 28Lisbon, Portugal, 28Lisbon, Portugal, 28----30 October 201530 October 201530 October 201530 October 2015
Financial Financial Financial Financial support for symposium attendeessupport for symposium attendeessupport for symposium attendeessupport for symposium attendees
ESCP News
ESCP News
ESCP News
ESCP News �� �� February 2016
February 2016
February 2016
February 2016 �� �� Number 170
Number 170
Number 170
Number 170 �� �� ISSN 135
ISSN 135
ISSN 135
ISSN 13533 33-- -- 0321
0321
0321
0321
Articles & Reports
6
Professor Steve Hudson presented a lec-ture at the European Association of Facul-ties of Pharmacy (EAFP) conference in June 2010 highlighting that pharmacy students should be competent, effective and advanced practitioners once they leave university. However, in real life, many newly graduate pharmacists are unable to perform their professional work as ex-pected. One important reason is that stu-dents have not been adequately trained with the necessary skills during their uni-versity studies. Professor Hudson identi-fied 3 major factors that are the main barriers in preparing pharmacy students to achieve high levels of competency before they leave university.
1. Language barrier: 1. Language barrier: 1. Language barrier: 1. Language barrier: Prof. Hudson has the opinion that pharmacy students have not been taught to speak the same language as doctors. It is a fact that, in the past, pharmacy students had a very limited opportunity to learn or practice working with doctors and other healthcare profes-sionals in a clinical environment. There-fore, doctors may not to provide pharma-cists with important medical information about the patients’ health status.
2. University bias2. University bias2. University bias2. University bias: until recently, universi-ties have not recognised the importance for students of learning in the clinical work-ing environment. In the past, the majority Faculty of Pharmacies have been estab-lished based on pharmaceutical sciences concepts. Consequently, the majority of academic staff are experts in pharmaceuti-cal sciences, such as pharmaceutical chemistry, pharmaceutical technology or pharmaceutical manufacturing. Thus, pharmacy students are more familiar working in the laboratory environment rather than working in the clinical environ-ment.
3. Real life clinical problems 3. Real life clinical problems 3. Real life clinical problems 3. Real life clinical problems are very com-plicated but pharmacy students are pri-marily trained to handle a single problem within a specialised concept. Professor Hudson emphasised that students are not prepared adequately prior to graduating for handle complex combinations of prob-lems.
I totally agree with Professor Hudson’s comments, our colleagues at the Faculty
of Pharmacy at Chiang Mai University have been working very hard work to break the three barriers identified. Since 2004, our faculty has offered a 6-year curriculum for pharmaceutical care (a PharmD. program). This program was optional as a 5-year program that was consistent with the ma-jority of University Pharmacy programs running in Thailand at that time. However, since 2010, this 6-year program has been mandatory for every pharmacy program in Thailand. Currently, there are two disci-plines within this 6-year program, pharma-ceutical sciences and pharmaceutical care.
Our current pharmaceutical care, PharmD program (revised in 2010) provides a contemporary professional curriculum with the essential knowledge and skills. Our goals are to educate pharmacy students to be highly qualified pharmacy practitioners. Beyond the classrooms and laboratories, our students have an opportunity to work and practice in the clinical environment and local community. Students in the first year are provided a general education e.g., general physics, mathematics and chemis-try. In year 2 and 3, they are taught the core pharmacy components e.g., physiol-ogy, pharmacology, medical chemistry, pharmaceutical technology, toxicology and basic pharmacotherapy. At the end of the 3rd year, students are required to work within a local community. The students will stay with people within rural communities for 7 days where they will learn to identify and help solve health problems in the community they living. In year four, the students learn more advanced pharmaco-therapy and pharmaceutical care, dispens-ing, and counselling. After the end of year 4, the students will be trained at a general hospital for 5 weeks and at a community pharmacy for 5 weeks under the supervi-sion of a qualified pharmacist. In the fifth year, students have the opportunity to learn more specialist topics in pharmaceu-tical care services and pharmaceutical care (elective and compulsory subjects).
The pharmaceutical care skill (a compul-sory course) consists of 4 different areas in which students have to participate, includ-ing acute care, ambulatory care, commu-nity pharmacy (or drug store) care and local community. In the acute care setting, students learn from real patients on medi-cal wards at the University Hospital. In ambulatory care setting, five outpatient clinics in three hospitals have been setup including, anticoagulation warfarin clinic, heart failure clinic, HIV clinic, oncology clinic and psychiatric clinic. Students iden-tify drug therapy problems and give coun-seling to real patients under supervision of
the faculty staff. In the community phar-macy setting, two university pharmacies have been setup. Students interview and assess real patients including dispensing medicines for these patients and provide home healthcare services under supervi-sion of the faculty team. In the local com-munity setting, students learn how to solve health problems and promote good health in the local community. The problems may or may not related to drug therapy and most of the time stu-dents have to work with community mem-bers and leaders. This course has been prepared for students in order to make sure that they have sufficient knowledge and clinical skills before undertaking clerk-ships in the sixth year. During the sixth year, students take seven 6-week clinical clerkship rotations. Three clerkships are compulsory and four are elective. The three compulsory clerkships consist of acute care, ambulatory care and commu-nity pharmacy care. Students can choose any four of the provided clerkships as electives (e.g., clinical research, therapeu-tic drug monitoring, pharmaceutical care for patients receiving chemotherapy, drug information services, pharmaceutical care in community, consumer health protection, medication system management) and students can also choose compulsory clerkships as elective clerkships as well. Overall, pharmacy students are trained and practice under real clinical and/or community environments for at least two thousand hours.
In order to overcome the three main barri-ers that Professor Hudson identified, we have revised our pharmacy teaching pro-gram in Thailand. We believe that our graduated pharmacy students are highly qualified pharmacy practitioners. They have been well prepared not only by learn-ing in classrooms but also by a significant amount of practical training in the clinical environment, working with doctors and other healthcare team as well as people in the local community.
Surarong ChinwongSurarong ChinwongSurarong ChinwongSurarong Chinwong [email protected]
44444444thththth ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy ESCP Symposium on Clinical Pharmacy
Lisbon, Portugal, 28Lisbon, Portugal, 28Lisbon, Portugal, 28Lisbon, Portugal, 28----30 October 201530 October 201530 October 201530 October 2015
Steve Hudson Lecture 2015Steve Hudson Lecture 2015Steve Hudson Lecture 2015Steve Hudson Lecture 2015 Breaking the barriers… Breaking the barriers… Breaking the barriers… Breaking the barriers…
Creating highly qualified pharmacy practitionersCreating highly qualified pharmacy practitionersCreating highly qualified pharmacy practitionersCreating highly qualified pharmacy practitioners
ESCP News
ESCP News
ESCP News
ESCP News �� �� February 2016
February 2016
February 2016
February 2016 �� �� Number 170
Number 170
Number 170
Number 170 �� �� ISSN 135
ISSN 135
ISSN 135
ISSN 13533 33-- -- 0321
0321
0321
0321
ESCP Conferences
7
14 December 2015 14 December 2015 14 December 2015 14 December 2015 Registration OpeningRegistration OpeningRegistration OpeningRegistration Opening
14 December 2015 14 December 2015 14 December 2015 14 December 2015 Abstract submission Abstract submission Abstract submission Abstract submission
OpeningOpeningOpeningOpening
15 March 2016 15 March 2016 15 March 2016 15 March 2016 Abstract submission Abstract submission Abstract submission Abstract submission
deadlinedeadlinedeadlinedeadline
15 March 2016 15 March 2016 15 March 2016 15 March 2016 Early bird registration Early bird registration Early bird registration Early bird registration
deadlinedeadlinedeadlinedeadline
2 May 2016 2 May 2016 2 May 2016 2 May 2016 Registration deadline for Registration deadline for Registration deadline for Registration deadline for abstract presenters abstract presenters abstract presenters abstract presenters
The number of partici-The number of partici-The number of partici-The number of partici-pants will be limited to pants will be limited to pants will be limited to pants will be limited to
135. 135. 135. 135.
15 December 201515 December 201515 December 201515 December 2015 Registration opening Registration opening Registration opening Registration opening
2 May 20162 May 20162 May 20162 May 2016 Abstract submission Abstract submission Abstract submission Abstract submission
opening opening opening opening
1 July 20161 July 20161 July 20161 July 2016 Abstract submission Abstract submission Abstract submission Abstract submission
deadlinedeadlinedeadlinedeadline
31 July 201631 July 201631 July 201631 July 2016 EarlyEarlyEarlyEarly----bird registration bird registration bird registration bird registration
deadline deadline deadline deadline
26 August 201626 August 201626 August 201626 August 2016 Notification to Abstract Notification to Abstract Notification to Abstract Notification to Abstract
SubmittersSubmittersSubmittersSubmitters
12 September 201612 September 201612 September 201612 September 2016 EarlyEarlyEarlyEarly----bird registration bird registration bird registration bird registration deadline for abstract deadline for abstract deadline for abstract deadline for abstract
presenters presenters presenters presenters
To learn more about the
programme and register, visit:
www.escpweb.org or mail
PresidencyPresidencyPresidencyPresidency Frank Jørgensen (NO) Organising Committee Organising Committee Organising Committee Organising Committee Anne Gerd Granås (NO) – Chair Liv Mathiesen (NO) Anne-Lise Sagen Major (NO) Kari Christiane Fougner Bjerknes (NO) Daniela Scala (IT) Edwin van Aalten (NL)
Scientific Committee Scientific Committee Scientific Committee Scientific Committee Frank Jørgensen (NO) – Chair Bart van den Bemt (NL) Olivier Bourdon (FR) Beate Garcia (NO) Stine Haustreis (NO) Fikret Vehbi Izzettin (TR) Carole Kaufmann (CH) Reidun L.S. Kjome (NO) Derek Stewart (GB) Janne Kutschera Sund (NO) Kirsten K. Viktil (NO)
45454545thththth European Symposium on Clinical Pharmacy, European Symposium on Clinical Pharmacy, European Symposium on Clinical Pharmacy, European Symposium on Clinical Pharmacy, jointly organized with NSFjointly organized with NSFjointly organized with NSFjointly organized with NSF
Oslo, Norway, 5Oslo, Norway, 5Oslo, Norway, 5Oslo, Norway, 5----7 October 20167 October 20167 October 20167 October 2016 Clinical pharmacy tackling inequalities Clinical pharmacy tackling inequalities Clinical pharmacy tackling inequalities Clinical pharmacy tackling inequalities
and access to health careand access to health careand access to health careand access to health care
ESCP International Workshop ESCP International Workshop ESCP International Workshop ESCP International Workshop Basel, Switzerland Basel, Switzerland Basel, Switzerland Basel, Switzerland To be confirmedTo be confirmedTo be confirmedTo be confirmed
Medication adherence: Medication adherence: Medication adherence: Medication adherence: from theory to daily patient carefrom theory to daily patient carefrom theory to daily patient carefrom theory to daily patient care
Pharmacists have the relevant kno-wledge relating to medicines and health to provide the patients with information they need to improve outcomes. They can coach and motivate patients to increase health literacy, use medications correctly, and adhere to treatment regi-mens. Thus, they represent the transitional zone between theory and patient care. In this Spring conference, our wish and vision is to promote methods of impro-ving adherence to healthcare professio-nals, such as, but not limited to, pharma-cists, physicians, nurses, dentists, psy-chologists, who think «««« A bird in the hand A bird in the hand A bird in the hand A bird in the hand is worth two birds in a bushis worth two birds in a bushis worth two birds in a bushis worth two birds in a bush ».».».». The International Workshop will start on Monday 13th June 2016. The two day will
provide a variety of plenary lectures alter-nating with workshops on different the-mes related to medication (non-) adhe-rence. The workshop will end on Tuesday 14th June in late afternoon. Plenary lecturesPlenary lecturesPlenary lecturesPlenary lectures • Setting the scene of non-adherence • Interventions to improve adherence • Patient involvement/shared decision making • Tele-health (e-health) Interactive workshopsInteractive workshopsInteractive workshopsInteractive workshops • Measuring adherence/detecting no-nadherent patients • Communication techniques • Tele-health / e-health • Implementation of interventions
Clinical pharmacists are frequently asked to advice on appropriate thera-pies, from either pharmaceutical/medical or economic perspectives. The main theme of the symposium reflects the increasingly widening gap between what is technologically possible to achieve with medicines, their increasing
cost, and what is affordable to society and individual patients. The final day of the symposium concerns long-term conditions in children and antimicrobial resistance, two major pub-lic health issues where appropriate use of medicines is vital to achieve good outcomes for patients and the society.
For Your DiaryFor Your DiaryFor Your DiaryFor Your Diary
ESSSSCP European Society of Clinical PharmacyEuropean Society of Clinical PharmacyEuropean Society of Clinical PharmacyEuropean Society of Clinical Pharmacy
ESCP News ESCP News ESCP News ESCP News is published by ESCP
Editor: Marie Caroline Husson (France)Editor: Marie Caroline Husson (France)Editor: Marie Caroline Husson (France)Editor: Marie Caroline Husson (France) Page Lay-out: Corinne Tollier (France) Language editing: Ian Millar (UK)
The contents of this publication are compiled in good faith. The publisher accepts no responsibility for omissions or errors.
ESCP International OfficeESCP International OfficeESCP International OfficeESCP International Office SIR Institute for Pharmacy Practice and Policy - Theda Man-sholtstraat 5b - NL-2331 JE Leiden - The Netherlands Tel: +31 645 915 831 - Fax : +31 71 5722431 E-mail: [email protected] / [email protected] www.escpweb.org
Deadline for the submission of material:Deadline for the submission of material:Deadline for the submission of material:Deadline for the submission of material: for issue number 171 is 2 April 2016.
ESCP News
ESCP News
ESCP News
ESCP News �� �� February 2016
February 2016
February 2016
February 2016 �� �� Number 170
Number 170
Number 170
Number 170 �� �� ISSN 135
ISSN 135
ISSN 135
ISSN 13533 33-- -- 0321
0321
0321
0321
Announcements
8
New MembersNew MembersNew MembersNew Members FranceFranceFranceFrance D'Ollone Estelle.......................... Paris Delage Clement ......................... Paris
GreeceGreeceGreeceGreece Panagi Zoi ................................Patras
Hong KongHong KongHong KongHong Kong Poon Ho Him.................... Hong Kong
ItalyItalyItalyItaly
Baldo Paolo .................... Portogruaro
KuwaitKuwaitKuwaitKuwait ............................................... Al-Taweel Dalal ..........................Safat
ScotlandScotlandScotlandScotland Cuthbert Melinda ................Broxburn
SwitzerlandSwitzerlandSwitzerlandSwitzerland Schneider Marie.................Lausanne Pfiffner Miriam .......................... Uster
TurkeyTurkeyTurkeyTurkey Tezcan Songul.......................Istanbul
2016 Membership fees 2016 Membership fees 2016 Membership fees 2016 Membership fees 1 year Full Membership ......................... € 85 3 years Full Membership........................ € 215 5 years Full Membership........................ € 340 Student Membership.............................. € 25
Dual member ship (SFPC or SIFO)Dual member ship (SFPC or SIFO)Dual member ship (SFPC or SIFO)Dual member ship (SFPC or SIFO) 1 year.........................................................€ 70 3 years .......................................................€ 175 Student fee ...............................................€ 20
Membership Membership Membership Membership 2016201620162016 Address: http://www.escpweb.orghttp://www.escpweb.orghttp://www.escpweb.orghttp://www.escpweb.org
2016201620162016
To be confirmedTo be confirmedTo be confirmedTo be confirmed Basel (Switzerland)
ESCP International Workshop « Medication adherence: from theory to daily patient care »
5555----7 October7 October7 October7 October Oslo (Norway)
45th ESCP Symposium on Clinical Pharmacy « Clinical pharmacy tackling inequalities and access to health care »